Trial Identifier: | ACE-LY-106 |
Sponsor: | AcertaPharma |
Collaborator: |
AstraZeneca
|
NCTID:: | NCT02717624 |
Start Date: | April 2016 |
Primary Completion Date: | June 2022 |
Study Completion Date: | August 2027 |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
Language | Description |
English Version |
Country | Location |
---|---|
US, OH | Columbus, OH, US, 43210 |
US, OH | Columbus, OH, US, 43210 |
US, OH | Columbus, OH, US, 43210 |
US, OH | Columbus, OH, US, 43210 |
US, OH | Columbus, OH, US, 43210 |
US, OH | Columbus, OH, US, 43210 |
US, OH | Columbus, OH, US, 43210 |
US, OH | Columbus, OH, US, 43210 |
US, OH | Columbus, OH, US, 43210 |
US, OH | Columbus, OH, US, 43210 |
US, OH | Columbus, OH, US, 43210 |
US, OH | Columbus, OH, US, 43210 |
US, OH | Columbus, OH, US, 43210 |
US, OH | Columbus, OH, US, 43210 |
US, OH | Columbus, OH, US, 43210 |